Surui Medical and Medtronic Forge Strategic Partnership to Advance Surgical Robotics Innovation

SHANGHAI, Oct. 24, 2021 /PRNewswire/ -- On Oct. 21, 2021, the "Beijing Shurui and Medtronic Strategic Partnership Signing Ceremony" was successfully held in Shanghai. Prof. Xu Kai, Founder of Beijing Shurui Technology Co., Ltd. and a professor at Shanghai Jiao Tong University, and Mr. Gu Yushao, President of Medtronic Greater China, attended the signing ceremony. Through this collaboration, both parties will jointly explore commercial and technical cooperation opportunities in the field of surgical robots, and work together to advance the technological and industrial development of China's surgical robot sector, ultimately benefiting patients and healthcare professionals worldwide. Also in attendance were Mr. Xiao Zhi, Director of Beijing Shurui Technology Co., Ltd. and Head of the Life Sciences Team at SDIC Capital; Mr. Guan Jifeng, Director of Beijing Shurui Technology Co., Ltd. and Founding Partner of TF Capital; Mr. Deng Jian, Vice President of Business Operations Services, Medtronic Greater China; and Mr. Noah Friedman, Vice President of Commercial Enablement and Digital Market Expansion, Medtronic Greater China.

“Beijing Shurui Technology Co., Ltd. is an emerging high-tech surgical robotics company in China. It has successfully developed a universal single-port and multi-port minimally invasive laparoscopic surgical robot system along with supporting surgical instruments, possessing complete independent intellectual property rights. The company has mastered key core technologies across the entire value chain and has established its own intellectual property protection system,” Professor Xu Kai introduced. “Earlier this year, the SHURUI laparoscopic surgical robot completed Asia’s first pure single-port robotic radical prostatectomy and partial nephrectomy. In the ongoing registration clinical trials, the SHURUI system has demonstrated excellent performance. Surgeries performed via the single-port approach further minimize patient trauma, while ensuring smooth surgical workflows and precise instrument movements. The company is currently advancing the medical device registration process and commercialization deployment for the laparoscopic surgical robot, and will continue to dedicate itself to the research and development of innovative surgical robotic technologies and products.”

At the signing ceremony, Professor Xu Kai and President Gu Yushao delivered remarks in succession, introducing the areas for upcoming cooperation, expressing their high expectations for the strategic partnership between the two parties, and wishing the collaboration a complete success.

Leveraging this strategic cooperation opportunity, Beijing Shurui aims to pioneer the widespread clinical adoption of SHURUI surgical robots in urology and gynecological surgery, while leading the trend toward more advanced single-port procedures, thereby driving the market promotion and practical implementation of advanced Chinese surgical robotics technologies backed by proprietary intellectual property rights. Furthermore, in the research and development of next-generation, cross-procedure, platform-based surgical robots, Beijing Shurui will seek synergistic integration with major strategic partners in domains such as energy devices and digital healthcare, ultimately harnessing innovation to benefit a broader patient population.